Comorbidity burden and characterization of psoriasis patients with concurrent psoriatic arthritis in the Corrona Psoriasis Registry - 11/08/17
Bruce Strober, MD, University of Connecticut Health Center; Chitra Karki, MPH, Corrona, LLC; Marc A Mason, MS, Corrona, LLC; Ning Guo, Corrona, LLC; Jeffrey D Greenberg, MD, NYU School of Medicine and Corrona, LLC; Mark Lewohl, MD, Icahn School of Medicine at Moutn Sinai
Le texte complet de cet article est disponible en PDF. Commercial support: This study is sponsored by Corrona, LLC. Corrona Psoriasis Registry is sponsored by Corrona LLC and is funded by AbbVie, Boehringer Ingelheim, Eli Lilly and Company and Novartis Pharmaceutical Corporation. Corrona, LLC has been supported through contracted subscriptions in the last two years by AbbVie, Amgen, AstraZeneca, BMS, Crescendo, Eli Lilly and Company, Genentech, GSK, Horizon Pharma USA, Janssen, Momenta Pharmaceuticals, Novartis, Pfizer, Roche and UCB. |
Vol 76 - N° 6S1
P. AB77 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?